Abstract
The aim of the study was to investigate the metabolic clearance rate (MCR) and the secretion rate (SR) of calcitonin (CT) in elderly men and women (mean age ± SE: 75 ± 3 and 78 ± 3 yr, respectively). The basal levels of CT were higher in men than in women (9.6 ± 3.2 vs 6.0 ± 1.5 pg/ml; p< 0.05). The MCR was not significantly different between sexes (905 ± 54.2 vs 810 ± 165.1 l/day). In contrast, CT SR was significantly higher in male subjects compared to women (8.7 ± 3.1 vs 4.8 ± 1.5 MQ/day; p < 0.05). These findings suggest that only a few units of CT are secreted daily by elderly subjects and that the lower basal values of the hormone in women are probably the result of a lower production rate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Passeri M., Palummeri E, Pedrazzoni M., Cervellin G., Barbagallo M., Butturini L, Di Ruvo R. The pathophysiology of calcitonin in man. Int. J. Tissue Reac. 8: 255,1986.
Austin LA, Heath H., III. Calcitonin: physiology and pathophysiology. N.Engl. J. Med. 304:269, 1981.
O’Riordan J.L.H., Aurbach G.D. Mode of action of thyrocalcitonin. Endocrinology 82: 377,1968.
Bijvoet O.L.M., Van Der Sluys V., Jensen A.P. Effects of calcitonin on patients with Paget’s disease, thyrotoxicosis and hypercalcemia. Lancet 7:876,1968.
Heath H., Body J.J., Fox J. Radioimmunoassay of calcitonin in normal human plasma: problems, perspectives and prospects. Biomed. Pharmacother. 38: 241,1984.
Tiegs R.D., Body J.J., Barta J.M., Heath H., III. Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage. J. BoneMin. Res. 7:339, 1986.
Deftos L.J., Weisman M.H., Willimas G.W., Karpf D.B., Drumar A.M., Davidson B.J., Parthemore J.G., Judd H.L Influence of age and sex on plasma calcitonin in human being. N.Engl. J. Med. 302:1351,1980.
Heath H., III, Sizemore G.W. Plasma calcitonin in normal man. Differences between men and women. J. Clin. Invest. 60:1135,1977.
Body J.J., Heath H., III. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J. Clin. Endocrinol. Metab. 57: 897,1983.
Chesnut C.H., III, Baylink D.J., Sisom K., Nelp W.B., Roos B.A. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis. Metabolism 29: 559, 1980.
Taggart H.M. Chesnut C.H., III, Ivey G.L., Baylink D.J., Sisom K., Huber M.B., Roos B.A. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet 1: 145, 1982.
Tiegs R.D., Body J.J., Wahner H.W., Barta J., Riggs B.L, Heath H., III. Calcitonin secretion in postmenopausal osteoporosis. N. Engl. J. Med. 312:1097,1985.
Hurley D.L, Tiegs R.D., Wahner H.W., Heath H., III. Axial and appendicular bone mineral density in patients with long term deficiency or excess of calcitonin. N.Engl. J. Med. 317: 537, 1987.
Reginster J.Y., Droisy R., Albert A., Denis D., Lecart M.P., Collette J., Franchimont P. Relationship between whole plasma calcitonin levels, calcitonin secretory capacity and plasma levels of estrone in healthy women and postmenopausal osteoporosis. J. Clin. Invest. 83:1073,1989.
Ardaillou R., Sizonenko P., Meyrier A, Vallee G., Beaugas C. Metabolic clearance rate of radioiodinated human calcitonin in man. J. Clin. Invest. 49:2345,1970.
Huwyler R., Born W., Ohnhaus E.E., Fischer J.A. Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man. Am. J. Physiol. 236: E15,1979.
Kanis J.A., Heynen G., Cundy T., Cornet F., Paterson A., Russell R.G.G. An estimate of the endogenous secretion rate of calcitonin in man. Clin. Sci. 63:145,1982.
Cecchettin M., Tarquini B., Miolo M., Conte N. The endogenous secretion rate of human calcitonin in normal conditions. Biomed. Pharmacother. 40:19,1985.
Endres D.B., Cornell M.E., Nelson J.C., Cantor T.L Calcitonin in normal individuals with a sensitive, specific radioimmunoassay. Calcif. Tissue. Int. 36: 476,1984.
Pedrazzoni M., Mantovani M., Ciotti G., Girasole G., Pioli G., Palummeri E. Calcitonin levels in normal women of various ages evaluated with a new sensitive radioimmunoassay. Horm. Metab. Res. 20:118, 1988.
Gagel R.F., Tashjian A.H. Jr, Cummings T., Papatha-nasopoulos N., Kaplan M.M., DeLellis R.A., Wolfe H.J., Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. A 18-year experience. N. Engl. J. Med. 318:478,1988.
Tait J.F. Review: the use of isotopic steroids for the measurement of production rates in vivo. Anal. Biochem. 90:1,1978.
Body J.J., Heath H., III. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J. Clin. Endocrinol. Metab. 57: 897,1983.
MacIntyre I., Stevenson J.C., Whitehead M.I., Wima-lawansa S.J., Banks L.M., Healy M.J.R. Calcitonin for the prevention of postmenopausal bone loss. Lancet 7:900,1988.
Avioli L.V. The future for calcitonin in osteoporotic syndromes. In: Christiansen C, Johansen J.S., Riis B.J. (Eds.), Osteoporosis 1987. Osteopress ApS, Copenhagen, 1987, p. 1233.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pedrazzoni, M., Ciotti, G., Davoli, L. et al. Calcitonin secretion rate in elderly normal subjects. J Endocrinol Invest 13, 501–505 (1990). https://doi.org/10.1007/BF03348608
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348608